This activity is supported by educational grants from Purdue Pharma LP, Teva Pharmaceuticals, and Zogenix, Inc.
Mara N. Villanueva, PharmD
Clinical Pharmacy Specialist
Pharmacy Medication Management
The University of Texas
MD Anderson Cancer Center
At the conclusion of this educational activity, participants should be able to:
Examine the risk factors associated with the highest rates of opioid overdose.
Identify the characteristics and red flags of patients who intend to use or distribute opioids for non-medical reasons.
Review the information that is important to communicate to patients regarding appropriate opioid medication use, storage, and disposal.
Describe how pharmacists can support the current Risk Evaluation and Mitigation Strategy programs for extended-release, long-acting, and transmucosal immediate-release fentanyl opioid products, and identify the tools available to prevent opioid misuse, diversion, and abuse.
July 8, 2014
July 8, 2016
Estimated time to complete activity:
Click here to view this activity.
to view this activity. - See more at: http://www.pharmacytimes.com/publications/issue/2014/June2014/Optimizing-the-Management-of-Asthma-The-Critical-Role-of-the-Pharmacist#sthash.7ZeRdjp8.dpuf
to view this activity.
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-14-062-H03-P. The activity is available for CE credit through July 8, 2016.